Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Liabilities and Shareholders Equity (2022 - 2025)

Historic Liabilities and Shareholders Equity for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $53.4 million.

  • Jin Medical International's Liabilities and Shareholders Equity rose 1652.28% to $53.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.2 million, marking a year-over-year increase of 2600.23%. This contributed to the annual value of $53.4 million for FY2025, which is 1652.28% up from last year.
  • Latest data reveals that Jin Medical International reported Liabilities and Shareholders Equity of $53.4 million as of Q3 2025, which was up 1652.28% from $45.8 million recorded in Q3 2024.
  • In the past 5 years, Jin Medical International's Liabilities and Shareholders Equity ranged from a high of $53.4 million in Q3 2025 and a low of $20.9 million during Q3 2022
  • Its 4-year average for Liabilities and Shareholders Equity is $38.3 million, with a median of $39.4 million in 2023.
  • As far as peak fluctuations go, Jin Medical International's Liabilities and Shareholders Equity skyrocketed by 5713.55% in 2023, and later skyrocketed by 1652.28% in 2025.
  • Over the past 4 years, Jin Medical International's Liabilities and Shareholders Equity (Quarter) stood at $20.9 million in 2022, then skyrocketed by 57.14% to $32.9 million in 2023, then skyrocketed by 39.2% to $45.8 million in 2024, then increased by 16.52% to $53.4 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $53.4 million for Q3 2025, versus $45.8 million for Q3 2024 and $32.9 million for Q3 2023.